Exact Sciences Corporation has approved new compensation arrangements for its named executive officers in connection with its pending merger with Abbott Laboratories. Under the approved agreements, executive officers will receive accelerated vesting and payment of their fiscal year 2025 annual bonuses, with performance deemed at 115% of target. Additionally, certain restricted stock unit (RSU) and performance share unit (PSU) awards granted prior to the merger agreement will vest early, with PSU awards vesting at varying percentages of target based on their grant year. Specifically, CEO Kevin Conroy will receive an accelerated 2025 annual bonus of $436,056 and 713,931 shares subject to PSU awards, while CFO Jeff Elliott will receive an accelerated bonus of $507,150 and 63,099 RSU shares. Accelerated payments are subject to clawback if employment ends under certain circumstances, and executives may receive additional payments if actual performance exceeds the accelerated performance levels.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. EXACT Sciences Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-332352), on December 29, 2025, and is solely responsible for the information contained therein.